Data / Drug companies / Direct_Rx
Direct_Rx: 539 products in the FDA NDC directory, labeler code 72189
Direct_Rx (labeler code 72189) lists 539 products in the FDA National Drug Code Directory, covering 239 finished drugs by generic name. By type: 539 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 30, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72189
- Products in commercial distribution
- 539
- Packages
- 978
- Finished drugs by generic name
- 239
- Prescription products
- 539
- Over the counter products
- 0
- Controlled substance products
- Schedule II 21, Schedule III 6, Schedule IV 28, Schedule V 11
- Started marketing in the last 12 months
- 48
- Products with a marketing end date set
- 4
- Earliest marketing start
- June 18, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 511 | 94.8% |
| New drug applications (NDA) | 11 | 2% |
| Other unapproved drugs | 10 | 1.9% |
| Authorized generics (NDA) | 7 | 1.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 539 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 216 | 40.1% |
| Tablet, film coated | 121 | 22.4% |
| Capsule | 73 | 13.5% |
| Tablet, extended release | 29 | 5.4% |
| Cream | 15 | 2.8% |
| Solution | 10 | 1.9% |
| Ointment | 9 | 1.7% |
| Capsule, extended release | 9 | 1.7% |
| Powder, for suspension | 8 | 1.5% |
| Capsule, delayed release | 7 | 1.3% |
| Tablet, coated | 6 | 1.1% |
| Tablet, film coated, extended release | 6 | 1.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Levetiracetam | 72189-696 | Tablet, film coated | Generic drugs (ANDA) | October 30, 2026 |
| Celecoxib | 72189-695 | Capsule | Generic drugs (ANDA) | October 29, 2026 |
| Trazodone HCL | 72189-694 | Tablet | Generic drugs (ANDA) | October 12, 2026 |
| Guanfacine ER | 72189-693 | Tablet, extended release | Generic drugs (ANDA) | October 2, 2026 |
| Propranolol HCL ER | 72189-691 | Capsule, extended release | Generic drugs (ANDA) | September 29, 2026 |
| Lidocaine | 72189-692 | Ointment | Generic drugs (ANDA) | September 28, 2026 |
| Carvedilol | 72189-690 | Tablet, film coated | Generic drugs (ANDA) | September 23, 2026 |
| Amlodipine Besylate | 72189-689 | Tablet | Generic drugs (ANDA) | September 23, 2026 |
| Diclona Gel | 72189-688 | Gel | Other unapproved drugs | September 9, 2026 |
| Colchicine | 72189-687 | Tablet, film coated | Generic drugs (ANDA) | August 27, 2026 |
| Loperamide HCl | 72189-686 | Capsule | Generic drugs (ANDA) | August 25, 2026 |
| Celecoxib | 72189-685 | Capsule | Generic drugs (ANDA) | August 24, 2026 |
| Meloxicam | 72189-684 | Tablet | Generic drugs (ANDA) | August 12, 2026 |
| Meloxicam | 72189-683 | Tablet | Generic drugs (ANDA) | August 12, 2026 |
| Anastrozole | 72189-682 | Tablet | Generic drugs (ANDA) | August 3, 2026 |
| Atorvastatin Calcium | 72189-681 | Tablet, film coated | Generic drugs (ANDA) | July 15, 2026 |
| Cyclobenzaprine HCL | 72189-680 | Tablet, film coated | Generic drugs (ANDA) | June 29, 2026 |
| Levetiracetam | 72189-679 | Tablet | Generic drugs (ANDA) | June 25, 2026 |
| Ibuprofen Famotidine | 72189-667 | Tablet | Generic drugs (ANDA) | June 22, 2026 |
| Tizanidine | 72189-678 | Capsule | Generic drugs (ANDA) | June 16, 2026 |
| Metoprolol Tartrate | 72189-677 | Tablet | Generic drugs (ANDA) | June 1, 2026 |
| Bupropion HCL ER(SR) | 72189-676 | Tablet, extended release | Generic drugs (ANDA) | April 30, 2026 |
| Diclofenac Sodium D/R | 72189-675 | Tablet, delayed release | Generic drugs (ANDA) | April 28, 2026 |
| Lidothol ES Patch | 72189-674 | System | Other unapproved drugs | April 20, 2026 |
| Prednisone D/P | 72189-673 | Tablet | Generic drugs (ANDA) | April 9, 2026 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.